Attorney Advertising Material

23andMe Pharmaceutical Research Opt-Out Instructions

This page explains how to withdraw your consent to 23andMe’s pharmaceutical research program.

Important Links

What’s going on with 23andMe?

  • 23andMe is facing dozens of lawsuits following a massive data breach that it announced late last year, including a suit filed by Edelson PC. 23andMe’s financial position has since suffered, with the company risking being delisted from the Nasdaq because of its low stock price.1
  • While under these pressures, 23andMe’s CEO suggested that the company would share users’ genetic information with third parties for "research" purposes, allowing both 23andMe and “other groups” that it partners with to “mine the dataset” that 23andMe has accumulated.2
  • We believe that broadly sharing user genetic data would violate several state laws. So we asked 23andMe a number of questions about the scope of this data-mining program, who it intended to share data with, and how it would protect users. 23andMe refused to answer our questions or address our concerns. Instead, 23andMe says that users can opt out of data sharing and that this is just an expansion of an already-existing program.
  • While we will pursue legal claims regarding any unlawful sale or disclosure of users' information, we are concerned about any impending fire sale of users' data. We are therefore providing instructions for people to opt out of third party data sharing below. These easy-to-follow steps are in the video below, or you can follow the screenshots.
  • The attorneys appointed as interim class counsel to lead the litigation regarding 23andMe's data breach have established a case website, where they will post important case documents, transcripts, and case updates. Because that website exists, we will not separately post documents here.

footnote details[1] 1       Ashley Capoot, 23andMe considers splitting up company to revive stock price, CNBC (Feb. 8, 2024),

https://www.cnbc.com/2024/02/08/23andme-considers-splitting-up-company-to-revive-stock-price-.html.

2      Emily Mullin, 23andMe Is Under Fire. Its Founder Remains ‘Optimistic’, WIRED (Feb. 12, 2024), https://bit.ly/3OHbGqr (“We now have the ability to mine the dataset for ourselves, as well as to partner with other groups.”); Thomas Germain, 23andMe Admits ‘Mining’ Your DNA Data Is Its Last Hope, GIZMODO (Feb. 13, 2024), https://gizmodo.com/23andme-admits-mining-your-dna-data-is-its-last-hope-1851252582.

If you would like to discuss this case with an attorney from Edelson PC, fill out our contact form. 

By checking the box and submitting this form, you are agreeing to the Edelson PC Terms & Conditions and Privacy Policy, and that Edelson PC or others working with us may call you at the number you entered above, including possibly using automated text and/or pre-recorded messages. Standard rates apply.

Changing 23andMe Account Sharing Settings

Instructions

1. Log in to view your Account Settings.

2. Scroll down to see the Research and Product Consents panel, where you will see your current sharing settings. To change any of them, click the “Edit” button on the top right.

3. You will then see blue links to “Change consent” appear underneath each category. You can deactivate the consents using these options. 

4. We do not have complete information about what 23andMe believes each consent allows it to do, because 23andMe has not responded to our questions about the scope of its pharmaceutical research program, how it de-identifies data, and how it protects users once the data is shared. What 23andMe says about these consents is: 

a. The “23andMe Research Consent Document” purportedly allows 23andMe to include your de-identified genetic data in a pool of data with other research participants that could be shared with GSK and any other third-parties that it agrees to.

b. “Research opportunities based on your unreported genetics” purportedly allows 23andMe to contact you about studying “unreported” DNA variants that are not included in your 23andMe genetic reports.4 

c. The “Individual Data Sharing Consent” purportedly allows researchers access to de-identified genetic data “related to a single person”—i.e., your genetic information, as well as certain other self-reported information provided to 23andMe.5

d. The “Personalized Recommendations Consent” does not appear to relate to third-party sharing, but instead to recommendations made by 23andMe.6

5. Click on the consent you wish to withdraw. You will be taken to the consent document you selected. Scroll all the way down and you will be able to change your selection to “I DON’T GIVE CONSENT.” 

6. Click the “Submit” button and your change will be registered in your Account Settings.

© 2025 COPYRIGHT EDELSON PC. EDELSON® IS A REGISTERED MARK OF EDELSON PC. ALL RIGHTS RESERVED. 

ATTORNEY ADVERTISING.

Edelson PC. Attorney Advertising Material. 150 California Street, 18th Floor, San Francisco, California 94111.